ABRAHAM WEAVER: Open Payments
NPI 1548695588 · EDGEFIELD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 20 payments from 14 companies in 2025. Trend: 2023 $606 · 2024 $233 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Abbott Laboratories | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Dexcom, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: AIRSUPRA, LEQVIO, Ozempic, REXULTI, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Dexcom G6 Transmitter, VRAYLAR, ELIQUIS.
Industry payments across SC — which companies pay providers there.
